These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3009382)

  • 1. Reversible binding of polymyxin B and neomycin to the solid part of faeces.
    Hazenberg MP; Pennock-Schröder AM; van de Merwe JP
    J Antimicrob Chemother; 1986 Mar; 17(3):333-9. PubMed ID: 3009382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces.
    Hazenberg MP; Pennock-Schröder AM; Van den Boom M; Van de Merwe JP
    J Hyg (Lond); 1984 Aug; 93(1):27-34. PubMed ID: 6086749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibiotics on the human intestinal flora in mice.
    Hazenberg MP; Van de Boom M; Bakker M; Van de Merwe JP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):97-109. PubMed ID: 6351741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination.
    Hazenberg MP; Van de Boom M; Bakker M; Van de Merwe JP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):111-7. PubMed ID: 6351739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice.
    Emmelot CH; van der Waaij D
    J Hyg (Lond); 1980 Jun; 84(3):331-40. PubMed ID: 6300222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective decontamination and the anaerobic faecal flora.
    Hazenberg MP; Pennock-Schröder AM
    Antonie Van Leeuwenhoek; 1984; 50(5-6):683-9. PubMed ID: 6397135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium.
    Vaara M; Vaara T; Sarvas M
    J Bacteriol; 1979 Aug; 139(2):664-7. PubMed ID: 222738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium.
    Rogers MJ; Cohen J
    Infection; 1986; 14(2):79-81. PubMed ID: 3011678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
    Tempera G; Mangiafico A; Genovese C; Giudice E; Mastrojeni S; Nicolosi D; Ferneri PM
    Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of neuromuscular blocking effects of neomycin and polymyxin B.
    Lee C; de Silva AJ
    Anesthesiology; 1979 Mar; 50(3):218-20. PubMed ID: 219730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate.
    Booth JH; Benrimoj SI; Nimmo GR
    Int J Dermatol; 1994 Jul; 33(7):517-20. PubMed ID: 7928043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preservation in aqueous solution of vancomycin, neomycin and polymyxin B, alone or in combination. Statistical analysis of antibacterial activity according to the Pharmacopée Helvétique VI].
    Cornu J; Schorer E; Amacker PA
    Pharm Acta Helv; 1980; 55(10):253-5. PubMed ID: 6256778
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymyxin B binding sites in Escherichia coli as revealed by polymyxin B-gold labeling.
    Morioka H; Tachibana M; Machino M; Suganuma A
    J Histochem Cytochem; 1987 Feb; 35(2):229-31. PubMed ID: 3025293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoprotein.
    Azad MA; Huang JX; Cooper MA; Roberts KD; Thompson PE; Nation RL; Li J; Velkov T
    Biochem Pharmacol; 2012 Aug; 84(3):278-91. PubMed ID: 22587817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and functional determination of polymyxin B protein binding in serum.
    Abodakpi H; Gohlke J; Chang KT; Chow DS; Tam VH
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7121-3. PubMed ID: 26324262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absorption of antibiotics from the bladder.
    Chamberlain G; Needham P
    J Urol; 1976 Aug; 116(2):172-3. PubMed ID: 181601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin interaction with negatively charged lipid bilayer membranes and the competitive effect of Ca2+.
    Sixl F; Galla HJ
    Biochim Biophys Acta; 1981 May; 643(3):626-35. PubMed ID: 6264957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of polymyxin B nonapeptide to gram-negative bacteria.
    Vaara M; Viljanen P
    Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow microcalorimetric assay of antibiotics--I. Polymyxin B sulphate and its combinations with neomycin sulphate and zinc bacitracin on interaction with Bordetella bronchiseptica (NCTC 8344).
    Joslin Kjeldsen N; Beezer AE; Miles RJ
    J Pharm Biomed Anal; 1989; 7(7):851-7. PubMed ID: 2490093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance.
    Conrad RS; Galanos C
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1724-8. PubMed ID: 2556077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.